PALYNZIQ
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 31 Dec 2024)
What this means for you
Registered since 09 Oct 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87095019
- Registration number
- 5581302
- Mark type
- Stylized text
- Filed
- 06 Jul 2016
- Published for opposition
- 29 Nov 2016
- Registered
- 09 Oct 2018
- Attorney of record
- Gregory J. Chinlund
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for use in enzyme therapy
Owner
- Biomarin Pharmaceutical Inc., Novato, CA, US
- Biomarin Pharmaceutical Inc., Novato, CA, US
- Biomarin Pharmaceutical Inc., Novato, CA, US
Prosecution history
- 31 Dec 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 31 Dec 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 Dec 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Jul 2024 — TEAS SECTION 8 & 15 RECEIVED
- 09 Oct 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Dec 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Dec 2020 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 09 Dec 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Dec 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Oct 2018 — REGISTERED-PRINCIPAL REGISTER
- 07 Sept 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Sept 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Aug 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Jul 2018 — USE AMENDMENT FILED
- 20 Aug 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL